In-Person Access Only | 6.0 CME Credits & MOC Points
All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.
Our 7th Annual Best of Breast Conference will take place on January 17th and 18th, 2026. This innovative, state-of-the-art program brings together some of the world's leading breast cancer experts for a dynamic, multidisciplinary discussion. Topics will span high-risk disease characteristics, advances in adjuvant and metastatic treatment, interdisciplinary care strategies, and approaches to survivorship and recurrence- all while incorporating data from the major oncologic annual meetings.
Conference Agenda
Saturday, January 17, 2026
8:00 AM
Welcome and Opening Remarks
Reshma Mahtani, DO | Miami Cancer Institute, Baptist Health South Florida
8:10 AM
Optimizing Breast Imaging for Disease Staging and Post-Treatment Surveillance
Chris Comstock, MD | Weill Cornell Medical College
8:30 AM
Cutting-Edge Care: What’s New in Early-Stage Breast Cancer Surgery
Mehran Habibi, MD | Miami Cancer Institute, Baptist Health South Florida
8:30 AM
Cancer Survivorship in Focus: Addressing Toxicities and Quality of Life
Eleonora Teplinsky, MD| Valley Health
9:10 AM
Breakfast and Exhibits
9:25 AM
Non-CME Breakfast - Pfizer -
10:10 AM
The Game Changers: Systemic Therapy Updates You Can’t Miss
Neelima Vidula, MD | Massachusetts General Hospital
10:30 AM
Targeting with Precision: How Radiation Has Changed the Game in Breast Cancer
Laura Freedman, MD | University of Miami
10:50 AM
Supporting Patients Through Treatment: A Pharmacist’s Perspective on Toxicity Management (Recorded Session with Live Q&A)
Sonia Amin Thomas, PharmD | Philadelphia College of Osteopathic Medicine
11:10 AM
Lunch and Exhibits
11:25 AM
Non-CME Lunch
12:10 PM
Housekeeping & Survey
12:20 PM
Updates On Cancer Genetics
Jennifer Klemp, PhD | University of Kansas Cancer Center
12:20 PM
Are We Ready Yet? The Road to Liquid Biopsy Implementation
Jason Mouabbi, MD | MD Anderson
1:00 PM
Harnessing AI for Cancer Care: Opportunities and Challenges
Doug Flora, MD | St. Elizabeth Healthcare
1:20 PM
ADJOURN
Sunday, January 18, 2026
8:00 AM
Welcome and Opening Remarks
Connie Guaqueta, MD | Miami Cancer Institute, Baptist Health South Florida
8:10 AM
Refining Systemic Therapy in HR+/HER2+ Early Breast Cancer: What’s Changing in 2026?
Neelima Vidula, MD | Massachusetts General Hospital
8:30 AM
TNBC: Therapeutic Updates and Case Integration
Ana Sandoval-Leon, MD | Miami Cancer Institute, Baptist Health South Florida
8:50 AM
Axillary Management in HR+ and HER2+ Disease: Multidisciplinary Perspectives Panel Discussion
Connie Guaqueta, MD (Moderator) | Miami Cancer Institute, Baptist Health South Florida
Mehran Habibi, MD | Miami Cancer Institute, Baptist Health South Florida
Laura Freedman, MD | University of Miami
9:20 AM
Breakfast and Exhibits
9:35 AM
Non-CME Breakfast - Gilead -
10:20 AM
TNBC Choice of First Line Therapy (PDL1+ or Negative) How to Sequence After Progression of Disease
Abi Siva, MD | Medical University of South Carolina
10:40 AM
Sequencing Treatments for Her2+ Disease
Eleonora Teplinsky, MD | Valley Health
11:00 AM
Targeted Therapies in Hormone Receptor + Breast Cancer (Recorded Session with Live Q&A)
Seth Wander, MD, PhD | Massachusetts General Hospital
11:20 AM
Lunch and Exhibits
11:35 AM
Non-CME Lunch
12:20 PM
Management of Immunotherapy Toxicity
12:50 PM
Biosimilars in Oncology: Value, Vision, and the Road Ahead
Jorge Garcia, PharmD | Miami Cancer Institute, Baptist Health South Florida
1:20 PM
ADJOURN
Cancer Institute
Agenda Subject To Change. All times are EST.
-
Apply the current standards of oncology care and key updates from national clinical guidance pathways to optimize the management of patients with various breast cancers.
Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with breast cancer.
Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with breast cancer.
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 6.00 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 6.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 6.00 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources